These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 37675180)
1. The relationship between hormonal levels and hematological parameters in cystic ovarian syndrome. Al Kafhage FA; Abbas AN; Al-Masaoodi RA; Hassan S; Al-Shemery MK J Med Life; 2023 Jun; 16(6):937-940. PubMed ID: 37675180 [TBL] [Abstract][Full Text] [Related]
2. Prolactin and thyroid stimulating hormone affecting the pattern of LH/FSH secretion in patients with polycystic ovary syndrome: A hospital-based study from North East India. Nath CK; Barman B; Das A; Rajkhowa P; Baruah P; Baruah M; Baruah A J Family Med Prim Care; 2019 Jan; 8(1):256-260. PubMed ID: 30911516 [TBL] [Abstract][Full Text] [Related]
3. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Reyes FI; Winter JS; Faiman C Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845 [TBL] [Abstract][Full Text] [Related]
4. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. Timpatanapong P; Rojanasakul A J Dermatol; 1997 Apr; 24(4):223-9. PubMed ID: 9164062 [TBL] [Abstract][Full Text] [Related]
5. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women. Sanke S; Chander R; Jain A; Garg T; Yadav P JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study. Zhang HY; Guo CX; Zhu FF; Qu PP; Lin WJ; Xiong J Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387 [TBL] [Abstract][Full Text] [Related]
7. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary]. Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449 [TBL] [Abstract][Full Text] [Related]
8. A study of hormonal and anthropometric parameters in polycystic ovarian syndrome. Kambale T; Sawaimul KD; Prakash S Ann Afr Med; 2023; 22(1):112-116. PubMed ID: 36695232 [TBL] [Abstract][Full Text] [Related]
9. The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS. Li X; Yang D; Pan P; Azziz R; Yang D; Cheng Y; Zhao X Front Endocrinol (Lausanne); 2022; 13():873726. PubMed ID: 35769085 [TBL] [Abstract][Full Text] [Related]
10. Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome. Yang H; Lin J; Li H; Liu Z; Chen X; Chen Q Front Endocrinol (Lausanne); 2021; 12():571229. PubMed ID: 33716958 [TBL] [Abstract][Full Text] [Related]
11. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
12. Endocrine changes after laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovarian syndrome. Al-Ojaimi EH Saudi Med J; 2004 Aug; 25(8):1032-9. PubMed ID: 15322594 [TBL] [Abstract][Full Text] [Related]
13. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome. Deswal R; Nanda S; Dang AS Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034 [TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome. Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726 [TBL] [Abstract][Full Text] [Related]
15. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome. Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706 [TBL] [Abstract][Full Text] [Related]
16. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome. Köninger A; Koch L; Edimiris P; Enekwe A; Nagarajah J; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320 [TBL] [Abstract][Full Text] [Related]
17. Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome. Mansour A; Hashemi Taheri AP; Moradi B; Mohajeri-Tehrani MR; Qorbani M; Ghorbani Pashakolaee S; Sanginabadi M; Sajjadi-Jazi SM BMC Endocr Disord; 2022 Dec; 22(1):298. PubMed ID: 36456925 [TBL] [Abstract][Full Text] [Related]
18. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Kazerooni T; Dehghan-Kooshkghazi M Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019 [TBL] [Abstract][Full Text] [Related]
19. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age]. Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740 [TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow. Loverro G; Vicino M; Lorusso F; Vimercati A; Greco P; Selvaggi L Gynecol Endocrinol; 2001 Apr; 15(2):142-9. PubMed ID: 11379011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]